Title | Cancer Biology and Therapeutics [electronic resource] / edited by Joseph G. Cory, Andor Szentivanyi |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 1987 |
Connect to | http://dx.doi.org/10.1007/978-1-4757-9564-6 |
Descript | X, 276 p. online resource |
Section I Biochemistry of the Cancer Cell and Selectivity of Drug Action -- Biochemical Strategy of Cancer Cells and the Targeting of Chemotherapy with Tiazofurin, Acivicin, and Dipyridamole -- The Biological Bases for the Design of Anticancer Agents -- Biochemistry of Methotrexate: Teaching an Old Drug New Tricks -- Section II Biological and Clinical Implications of Tumor Cell Heterogeneity and Metastases -- Biological and Clinical Implications of the Stem Cell Concept in Human Malignancy -- Membrane Properties of Lewis Lung Tumor Cells with โLowโ and โHighโ Metastatic Capacity: Anti-metastatic Effect of a Glycosaminoglycan Biosynthesis Blocking Agent 5-Hexyl-2?-deoxyuridine (HUdR) -- Implications of Therapy-induced Genetic/Epigenetic Modulations of Tumor Progression and Tumor Cell Heterogeneity for the Treatment of Cancer -- Section III Approaches to the Treatment and Diagnosis of Cancer -- Site-directed Combination Chemotherapy -- Sugar Analogs and 5-Fluorouridine in Combination Chemotherapy -- New Strategies for the Improvement of Alkylating Antitumor Agents -- Application of Proton Nuclear Magnetic Resonance to Tumor Biology -- Section IV Clinical Advances and Problems in the Treatment of Human Tumors -- Relationships of Cell Biology to Therapy in Childhood Leukemia -- Clinical Cancer Treatment and Drug Resistance: The Interface of the Clinic and the Laboratory -- Section V Induction, Prevention, and Modulation of Cancer -- Nitrosamines and Human Cancer: Some Implications of Basic Research -- Molecular Mechanisms in Protection Against Carcinogenesis -- Antineoplastic Agents and Cancer Cell Differentiation -- Section VI Immunological Aspects of Neoplasia -- A Reappraisal of Cytotoxic Lymphocytes in Human Tumor Immunology -- From Tumor Relapse Prevention to Tumor Induction Prevention -- Participants